Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-temperature plasmas in a tokamak fusion test reactor.
Strachan JD, Bitter M, Ramsey AT, Zarnstorff MC, Arunasalam V V, Bell MG, Bretz NL, Budny R, Bush CE, Davis SL, Dylla HF, Efthimion PC, Fonck RJ, Fredrickson E, Furth HP, Goldston RJ, Grisham LR, Grek B, Hawryluk RJ, Heidbrink WW, Hendel HW, Hill KW, Hsuan H, Jaehnig KP, Jassby DL, Jobes F, Johnson DW, Johnson LC, Kaita R, Kampershroer J, Knize RJ, Kozub T, LeBlanc B, Levinton F, La Marche PH, Manos DM, Mansfield DK, McGuire K, McNeill DH, Meade DM, Medley SS, Morris W, Mueller D, Nieschmidt EB, Owens DK, Park H, Schivell J, Schilling G, Schmidt GL, Scott SD, Sesnic S, Sinnis JC, Stauffer FJ, Stratton BC, Tait GD, Taylor G, Towner HH, Ulrickson M, von Goeler S, Wieland R, Williams MD, Wong KL, Yoshikawa S, Young KM. Strachan JD, et al. Among authors: davis sl. Phys Rev Lett. 1987 Mar 9;58(10):1004-1007. doi: 10.1103/PhysRevLett.58.1004. Phys Rev Lett. 1987. PMID: 10034307 No abstract available.
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
Emiloju OE, Yin J, Koubek E, Reid JM, Borad MJ, Lou Y, Seetharam M, Edelman MJ, Sausville EA, Jiang Y, Kaseb AO, Posey JA, Davis SL, Gores GJ, Roberts LR, Takebe N, Schwartz GK, Hendrickson AEW, Kaufmann SH, Adjei AA, Hubbard JM, Costello BA. Emiloju OE, et al. Among authors: davis sl. Invest New Drugs. 2024 Feb;42(1):127-135. doi: 10.1007/s10637-024-01420-8. Epub 2024 Jan 25. Invest New Drugs. 2024. PMID: 38270822 Clinical Trial.
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors.
Schreiber AR, Kagihara JA, Corr BR, Davis SL, Lieu C, Kim SS, Jimeno A, Camidge DR, Williams J, Heim AM, Martin A, DeMattei JA, Holay N, Triplett TA, Eckhardt SG, Litwiler K, Winkler J, Piscopio AD, Diamond JR. Schreiber AR, et al. Among authors: davis sl. Cancers (Basel). 2023 Dec 23;16(1):91. doi: 10.3390/cancers16010091. Cancers (Basel). 2023. PMID: 38201519 Free PMC article.
384 results